BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Uterine cancer AND TOP2A, TOP2, TP2A
48 results:

  • 1. HPV16 E6 promoting cervical cancer progression through down-regulation of miR-320a to increase top2a expression.
    Zhang J; Yu X; Guo Y; Wang D
    Cancer Med; 2024 Feb; 13(3):e6875. PubMed ID: 38205938
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. [Expression of ProEXC and PRMT5 in cervical adenocarcinoma and their clinical significance].
    Cui HX; Lou XL; Xia W; Zhang YS; Cheng XY; Deng LF
    Zhonghua Yi Xue Za Zhi; 2023 Dec; 103(48):3967-3971. PubMed ID: 38129175
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Identification of Core Genes Shared by Endometrial cancer and Ovarian cancer Using an Integrated Approach.
    Ke Y; Zhuang X; You L
    Cell Mol Biol (Noisy-le-grand); 2022 Sep; 68(9):140-145. PubMed ID: 36905262
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Bioinformatics and cheminformatics approaches to identify pathways, molecular mechanisms and drug substances related to genetic basis of cervical cancer.
    Andalib KMS; Rahman MH; Habib A
    J Biomol Struct Dyn; 2023; 41(23):14232-14247. PubMed ID: 36852684
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Sequential gene expression analysis of cervical malignant transformation identifies RFC4 as a novel diagnostic and prognostic biomarker.
    Zhang J; Meng S; Wang X; Wang J; Fan X; Sun H; Ning R; Xiao B; Li X; Jia Y; Kong D; Chen R; Wang C; Ma D; Li S
    BMC Med; 2022 Nov; 20(1):437. PubMed ID: 36352434
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Role of APOA1 in the resistance to platinum-based chemotherapy in squamous cervical cancer.
    He Y; Han SB; Liu Y; Zhang JJ; Wu YM
    BMC Cancer; 2022 Apr; 22(1):411. PubMed ID: 35421932
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Bioinformatics Screening of Potential Biomarkers from mRNA Expression Profiles to Discover Drug Targets and Agents for Cervical cancer.
    Reza MS; Harun-Or-Roshid M; Islam MA; Hossen MA; Hossain MT; Feng S; Xi W; Mollah MNH; Wei Y
    Int J Mol Sci; 2022 Apr; 23(7):. PubMed ID: 35409328
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Clinical Utility of Reflex Testing with cancer Biomarkers to Improve Diagnostic Accuracy of Primary Human Papillomavirus Screening.
    Johnson LG; Saidu R; Svanholm-Barrie C; Boa R; Moodley J; Tergas A; Persing D; Campbell SA; Tsai WY; Wright TC; Denny L; Kuhn L
    Cancer Epidemiol Biomarkers Prev; 2022 Mar; 31(3):595-603. PubMed ID: 35027434
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Expression analysis of p16 and top2a protein biomarkers in cervical cancer lesions and their correlation with clinico-histopathological characteristics in a referral hospital, Tanzania.
    Zuberi Z; Mremi A; Chilongola JO; Semango G; Sauli E
    PLoS One; 2021; 16(10):e0259096. PubMed ID: 34705880
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. DFF40 deficiency in cancerous T cells is implicated in chemotherapy drug sensitivity and resistance through the regulation of the apoptotic pathway.
    Kulbay M; Johnson B; Fiola S; Diaz RJ; Bernier J
    Biochem Pharmacol; 2021 Dec; 194():114801. PubMed ID: 34678222
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Effects of Slide Storage on Detection of Molecular Markers by IHC and FISH in Endometrial cancer Tissues From a Clinical Trial: An NRG Oncology/GOG Pilot Study.
    Grushko TA; Filiaci VL; Montag AG; Apushkin M; Gomez MJ; Monovich L; Ramirez NC; Schwab C; Kesterson JP; Seward SM; Method MW; Olopade OI; Fleming GF; Birrer MJ
    Appl Immunohistochem Mol Morphol; 2022 Jan; 30(1):27-35. PubMed ID: 34224438
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Molecular differential analysis of uterine leiomyomas and leiomyosarcomas through weighted gene network and pathway tracing approaches.
    Sahly NN; Banaganapalli B; Sahly AN; Aligiraigri AH; Nasser KK; Shinawi T; Mohammed A; Alamri AS; Bondagji N; Elango R; Shaik NA
    Syst Biol Reprod Med; 2021 Jun; 67(3):209-220. PubMed ID: 33685300
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. top2a/MCM2, p16
    Del Moral-Hernández O; Hernández-Sotelo D; Alarcón-Romero LDC; Mendoza-Catalán MA; Flores-Alfaro E; Castro-Coronel Y; Ortiz-Ortiz J; Leyva-Vázquez MA; Ortuño-Pineda C; Castro-Mora W; Illades-Aguiar B
    BMC Cancer; 2021 Jan; 21(1):39. PubMed ID: 33413211
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Screening and Discovery of New Potential Biomarkers and Small Molecule Drugs for Cervical cancer: A Bioinformatics Analysis.
    Qiu HZ; Huang J; Xiang CC; Li R; Zuo ED; Zhang Y; Shan L; Cheng X
    Technol Cancer Res Treat; 2020; 19():1533033820980112. PubMed ID: 33302814
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Human Papillomavirus E7 Oncoprotein Promotes Proliferation and Migration through the Transcription Factor E2F1 in Cervical cancer Cells.
    Tian S; Zhang L; Li Y; Cao D; Quan S; Guo Y; Yang X; Yang T
    Anticancer Agents Med Chem; 2021; 21(13):1689-1696. PubMed ID: 33155930
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. top2a and CENPF are synergistic master regulators activated in cervical cancer.
    Yu B; Chen L; Zhang W; Li Y; Zhang Y; Gao Y; Teng X; Zou L; Wang Q; Jia H; Liu X; Zheng H; Hou P; Yu H; Sun Y; Zhang Z; Zhang P; Zhang L
    BMC Med Genomics; 2020 Oct; 13(1):145. PubMed ID: 33023625
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Identification of core genes in the progression of endometrial cancer and cancer cell-derived exosomes by an integrative analysis.
    Shi S; Tan Q; Feng F; Huang H; Liang J; Cao D; Wang Z
    Sci Rep; 2020 Jun; 10(1):9862. PubMed ID: 32555395
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Integrated analysis of key microRNAs /TFs /mRNAs/ in HPV-positive cervical cancer based on microRNA sequencing and bioinformatics analysis.
    Yuan Y; Shi X; Li B; Peng M; Zhu T; Lv G; Liu L; Jin H; Li L; Qin D
    Pathol Res Pract; 2020 Jun; 216(6):152952. PubMed ID: 32307200
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Identification of key genes and pathways of diagnosis and prognosis in cervical cancer by bioinformatics analysis.
    Yang HJ; Xue JM; Li J; Wan LH; Zhu YX
    Mol Genet Genomic Med; 2020 Jun; 8(6):e1200. PubMed ID: 32181600
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Molecular variations in uterine carcinosarcomas identify therapeutic opportunities.
    Crane E; Naumann W; Tait D; Higgins R; Herzog T; Brown J
    Int J Gynecol Cancer; 2020 Apr; 30(4):480-484. PubMed ID: 32114514
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 3.